The FDA label states that providers should consider discontinuing treatment if patients do not achieve at least 5% weight loss after 12 weeks at the maintenance dose, as continued use is unlikely to provide meaningful clinical benefit
This encompasses better control of blood sugar levels, lowered blood pressure, upgraded cholesterol profiles, and reduced inflammatory markers
However, the injectable GLP-1 agonist drugs had a role in helping the lipedema patients adhere to a lipedema specific diet, such as whats found in the Lymphedema andLipedema Nutrition Guide
Introduce Folate rich foods into your diet such as broccoli, beetroot, leafy greens, citrus fruits, eggs to name a few
Weight loss momentum continues, and resuming your established dose allows you to return to your treatment plan without significant setback
GLP-1 drugs, which have some side effects including nausea, were originally developed for diabetes, but research has increasingly suggested they could help with a broad range of health problems including addiction
